QSS
XLRN

Quantitative Systematic Strategies’s Acceleron Pharma XLRN Stock Holding History

Quantitative Systematic Strategies’s Portfolio XLRN Stock Details XLRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-6,166
Closed -$305K – 865
2015
Q4 		$305K Buy
+6,166
New +$222K 0.08% 512

Other funds holding XLRN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
ORI
Oak Ridge Investments Chicago, Illinois $1.51B AUM 37.25% 1-Year Est. Return
PVMCI
Polaris Venture Management Co IV Boston, Massachusetts $62.4M AUM 33.04% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quantitative Systematic Strategies's XLRN Position: Q1 2016 in Review

Quantitative Systematic Strategies sold out of Acceleron Pharma (XLRN) in Q1 2016, closing a stake of 6,166 shares — an estimated $305K sold.

Quantitative Systematic Strategies first reported a position in XLRN in Q4 2015 and held it in 1 quarter. The position peaked at $305K in Q4 2015. 128 funds tracked by Wall St. Rank hold XLRN as of Q1 2016.

  • Quantitative Systematic Strategies reported no remaining Acceleron Pharma position as of Q1 2016 after selling out during the quarter.
  • Quantitative Systematic Strategies sold 6,166 Acceleron Pharma shares in Q1 2016, an estimated $305K.
  • Quantitative Systematic Strategies first reported a position in Acceleron Pharma in Q4 2015 and held it in 1 quarter.
  • Quantitative Systematic Strategies's Acceleron Pharma position peaked at $305K in Q4 2015.
  • 128 funds tracked by Wall St. Rank held Acceleron Pharma as of Q1 2016.

Based on Quantitative Systematic Strategies's 13F filing for Q1 2016, filed 22 Apr 2016.